Patents by Inventor Moustafa El-Araby

Moustafa El-Araby has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BENZALDEHYDE COMPOUNDS WITH DIRECT POLYMER DESTABILIZING EFFECTS TO TREAT SICKLE CELL DISEASE
    Publication number: 20240109843
    Abstract: Compounds and methods for preventing and/or treating one or more symptoms of sickle cell diseases (SCD) by administering at least one of the compounds are provided. The compounds are chemically modified to increase bioavailability and activity, e.g., so that the compounds prevent adhesion and sickling of red blood cells (RBCs).
    Type: Application
    Filed: November 3, 2023
    Publication date: April 4, 2024
    Inventors: Martin SAFO, Yan ZHANG, Piyusha Pradeep PAGARE, Guoyan XU, Mohini GHATGE, Jurgen VENITZ, Osheiza ABDULMALIK, Andrew FLEISCHMAN, David LIGHT, Moustafa EL-ARABY, Abdelsattar OMAR
  • Potent antimicrobial compounds with a pyridazine nucleus
    Patent number: 11648248
    Abstract: Anti-microbial compounds having a pyridazine nucleus are provided. The compounds have anti-microbial (anti-biotic) properties and are used to treat infections caused by microbes, especially bacteria that are resistant to known antibiotics e.g. drug resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA).
    Type: Grant
    Filed: January 12, 2022
    Date of Patent: May 16, 2023
    Assignee: King Abdulaziz University
    Inventors: Moustafa El-Araby, Khaled Abouzid, Abdelsattar Omar, Maiy Jaballah, Khadijah Mohammad
  • Protein kinase and phosphatase inhibitors and methods for designing them
    Publication number: 20060030544
    Abstract: The present invention provides a method for identifying inhibitors of protein kinases and/or protein phosphatases. Methods are also provided for inhibiting protein kinase and/or protein phosphatase activity. Specific non-peptide protein tyrosine kinase and/or protein phosphatase inhibitors are provided. The protein kinase or protein phosphatase inhibitors of the present invention may be used to treat a number of conditions in patients, including cancer, psoriasis, arthrosclerosis, immune system activity, Type II diabetes, and obesity.
    Type: Application
    Filed: October 7, 2005
    Publication date: February 9, 2006
    Inventors: David Hangauer, Moustafa El-Araby, Karen Milkiewicz